421 related articles for article (PubMed ID: 15350543)
1. CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk.
Peters N; Opherk C; Zacherle S; Capell A; Gempel P; Dichgans M
Exp Cell Res; 2004 Oct; 299(2):454-64. PubMed ID: 15350543
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway.
Joutel A; Monet M; Domenga V; Riant F; Tournier-Lasserve E
Am J Hum Genet; 2004 Feb; 74(2):338-47. PubMed ID: 14714274
[TBL] [Abstract][Full Text] [Related]
3. Transendocytosis is impaired in CADASIL-mutant NOTCH3.
Watanabe-Hosomi A; Watanabe Y; Tanaka M; Nakagawa M; Mizuno T
Exp Neurol; 2012 Jan; 233(1):303-11. PubMed ID: 22079830
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a recurrent missense mutation in Notch3 in CADASIL.
Haritunians T; Chow T; De Lange RP; Nichols JT; Ghavimi D; Dorrani N; St Clair DM; Weinmaster G; Schanen C
J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1242-8. PubMed ID: 16107360
[TBL] [Abstract][Full Text] [Related]
5. A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling.
Karlström H; Beatus P; Dannaeus K; Chapman G; Lendahl U; Lundkvist J
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17119-24. PubMed ID: 12482954
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Ruchoux MM; Domenga V; Brulin P; Maciazek J; Limol S; Tournier-Lasserve E; Joutel A
Am J Pathol; 2003 Jan; 162(1):329-42. PubMed ID: 12507916
[TBL] [Abstract][Full Text] [Related]
7. CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand.
Haritunians T; Boulter J; Hicks C; Buhrman J; DiSibio G; Shawber C; Weinmaster G; Nofziger D; Schanen C
Circ Res; 2002 Mar; 90(5):506-8. PubMed ID: 11909813
[TBL] [Abstract][Full Text] [Related]
8. An animal model for the molecular genetics of CADASIL. (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy).
Fryxell KJ; Soderlund M; Jordan TV
Stroke; 2001 Jan; 32(1):6-11. PubMed ID: 11136906
[TBL] [Abstract][Full Text] [Related]
9. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia.
Kalimo H; Ruchoux MM; Viitanen M; Kalaria RN
Brain Pathol; 2002 Jul; 12(3):371-84. PubMed ID: 12146805
[TBL] [Abstract][Full Text] [Related]
10. CADASIL mutations impair Notch3 glycosylation by Fringe.
Arboleda-Velasquez JF; Rampal R; Fung E; Darland DC; Liu M; Martinez MC; Donahue CP; Navarro-Gonzalez MF; Libby P; D'Amore PA; Aikawa M; Haltiwanger RS; Kosik KS
Hum Mol Genet; 2005 Jun; 14(12):1631-9. PubMed ID: 15857853
[TBL] [Abstract][Full Text] [Related]
11. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients.
Joutel A; Andreux F; Gaulis S; Domenga V; Cecillon M; Battail N; Piga N; Chapon F; Godfrain C; Tournier-Lasserve E
J Clin Invest; 2000 Mar; 105(5):597-605. PubMed ID: 10712431
[TBL] [Abstract][Full Text] [Related]
12. The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo.
Monet M; Domenga V; Lemaire B; Souilhol C; Langa F; Babinet C; Gridley T; Tournier-Lasserve E; Cohen-Tannoudji M; Joutel A
Hum Mol Genet; 2007 Apr; 16(8):982-92. PubMed ID: 17331978
[TBL] [Abstract][Full Text] [Related]
13. Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains.
Dichgans M; Ludwig H; Müller-Höcker J; Messerschmidt A; Gasser T
Eur J Hum Genet; 2000 Apr; 8(4):280-5. PubMed ID: 10854111
[TBL] [Abstract][Full Text] [Related]
14. A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL.
Dotti MT; De Stefano N; Bianchi S; Malandrini A; Battisti C; Cardaioli E; Federico A
Arch Neurol; 2004 Jun; 61(6):942-5. PubMed ID: 15210536
[TBL] [Abstract][Full Text] [Related]
15. [Molecular basis and physiopathogenic mechanisms of CADASIL: a model of small vessel diseases of the brain].
Joutel A; Tournier-Lasserve E
J Soc Biol; 2002; 196(1):109-15. PubMed ID: 12134625
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation.
Campos AH; Wang W; Pollman MJ; Gibbons GH
Circ Res; 2002 Nov; 91(11):999-1006. PubMed ID: 12456485
[TBL] [Abstract][Full Text] [Related]
17. NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL.
Dichgans M; Herzog J; Gasser T
Neurology; 2001 Nov; 57(9):1714-7. PubMed ID: 11706120
[TBL] [Abstract][Full Text] [Related]
18. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: phenotypic and mutational spectrum.
Dichgans M
J Neurol Sci; 2002 Nov; 203-204():77-80. PubMed ID: 12417361
[TBL] [Abstract][Full Text] [Related]
19. Determination of Blood NOTCH3 Extracellular Domain and Jagged-1 Levels in Healthy Subjects.
Kim H; Jang B; Kim YJ; Choi JC
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142458
[TBL] [Abstract][Full Text] [Related]
20. [NOTCH3 gene mutations in four Chinese families with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy].
Wang ZX; Lu H; Zhang Y; Bu DF; Niu XY; Zhang Z; Huang YN; Yuan Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1175-80. PubMed ID: 15387979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
